索安非托

{{Drugbox
| Verifiedfields =
| Watchedfields =
| verifiedrevid =
| image = Solriamfetol.svg
| width =

| pronounce =
| tradename = Sunosi
| Drugs.com =
| MedlinePlus = a619040
| license_CA =
| license_EU =
| DailyMedID = Solriamfetol
| license_US = Sunosi
| pregnancy_AU =
| pregnancy_AU_comment =
| pregnancy_category=
| routes_of_administration = By mouth
| class = Norepinephrine–dopamine reuptake inhibitors
| ATC_prefix = N06
| ATC_suffix = BA14
| ATC_supplemental =

| legal_AU =
| legal_AU_comment =
| legal_BR =
| legal_BR_comment =
| legal_CA = Rx-only
| legal_CA_comment =
| legal_DE =
| legal_DE_comment =
| legal_NZ =
| legal_NZ_comment =
| legal_UK =
| legal_UK_comment =
| legal_US = Schedule IV
| legal_US_comment = 等），也叫索利氨酯，是一种有机化合物，分子式C10H14N2O2，可用于治疗睡眠呼吸暂停和發作性嗜睡病。

2026年，该药物在中国大陆被列为第二类精神药品。

参考文献
外部链接
*
*